Vertex Pharmaceuticals (VRTX) Short term Debt (2009 - 2016)
Vertex Pharmaceuticals (VRTX) posted Short term Debt of $300.0 million for Q4 2016, up 0.76% on a QoQ basis from $297.8 million in Q3 2016, and up 320.78% year-over-year from $71.3 million in Q1 2016.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Short term Debt (2009 - 2016) Analysis & Trends
Vertex Pharmaceuticals has reported Short term Debt for 6 years, with the latest figure at $300.0 million in Q4 2016.
- On a quarterly basis, Short term Debt rose 320.78% year-over-year to $300.0 million in Q4 2016; TTM through Dec 2016 was $300.0 million, a 320.78% increase from a year earlier, with the FY2016 full-year figure at $300.0 million, up 320.78% from the prior year.
- Short term Debt was $300.0 million for Q4 2016 at Vertex Pharmaceuticals, up from $297.8 million in the prior quarter.
- The five-year high for Short term Debt was $300.0 million in Q4 2016, with the low at $14.2 million in Q4 2014.
- Average Short term Debt over 3 years is $140.3 million, with a median of $108.8 million recorded in 2015.
- The largest YoY upside for Short term Debt was 416.82% in 2016 against a maximum downside of 320.78% in 2016.
- Over 3 years, Short term Debt stood at $14.2 million in 2014, then jumped by 401.87% to $71.3 million in 2015, then surged by 320.78% to $300.0 million in 2016.
- The last three Short term Debt figures came in at $300.0 million (Q4 2016), $297.8 million (Q3 2016), and $221.6 million (Q2 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 300.00 Mn |
| Sep 30, 2016 | 297.75 Mn |
| Jun 30, 2016 | 221.58 Mn |
| Mar 31, 2016 | 146.25 Mn |
| Dec 31, 2015 | 71.30 Mn |
| Jun 30, 2015 | 42.87 Mn |
| Mar 31, 2015 | 28.53 Mn |
| Dec 31, 2014 | 14.21 Mn |
| Sep 30, 2011 | 98.42 Mn |
| Mar 31, 2011 | 92.10 Mn |
| Dec 31, 2010 | 136.99 Mn |
| Sep 30, 2010 | 45.28 Mn |
| Jun 30, 2010 | 45.78 Mn |
| Dec 31, 2009 | 32.07 Mn |
API Access
Vertex Pharmaceuticals Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();